Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Spyros A Papiris

Showing results (11-20 of 93) with videos related to

Pageof 10
Sort By:
Lung|November 13, 2013
Treating CTDs related fibrotic ILDs by immunosuppressants: "facts and faults"Spyros A Papiris, Konstantinos Kagouridis, Georgia Papadaki, et al.
Drugs|November 17, 2009
Acute severe asthma: new approaches to assessment and treatmentSpyros A Papiris, Effrosyni D Manali, Likurgos Kolilekas, et al.
Drug Safety|June 18, 2010
Amiodarone: review of pulmonary effects and toxicitySpyros A Papiris, Christina Triantafillidou, Likurgos Kolilekas, et al.
Frontiers in Pharmacology|May 2, 2022
IPF-Acute Exacerbations: Advances and Future PerspectivesSpyros A Papiris, Lykourgos Kolilekas, Konstantinos Kagouridis, et al.
Environmental Health : a Global Access Science Source|August 31, 2021
Long-term personal air pollution exposure and risk for acute exacerbation of idiopathic pulmonary fibrosisIoannis Tomos, Konstantina Dimakopoulou, Effrosyni D Manali, et al.
Expert Review of Respiratory Medicine|March 25, 2014
Idiopathic pulmonary fibrosis acute exacerbations: where are we now?Spyros A Papiris, Konstantinos Kagouridis, Likurgos Kolilekas, et al.
Expert Review of Respiratory Medicine|November 8, 2023
Effects of short-term air pollution exposure on symptoms development in the course of idiopathic pulmonary fibrosisKonstantina Dimakopoulou, Ioannis Tomos, Effrosyni D Manali, et al.
Pneumonologia I Alergologia Polska|September 18, 2015
"Luck's always to blame": silent wounds of a penetrating gunshot trauma sustained 20 years agoIoannis Tomos, Effrosyni D Manali, Stylianos Argentos, et al.
The Lancet. Respiratory Medicine|June 24, 2026
Pulmonary fibrosis in chILD: bridging the gapEffrosyni D Manali, Nadia Nathan, Lykourgos Kolilekas, et al.
American Journal of Respiratory and Critical Care Medicine|March 3, 2012
Steroids in idiopathic pulmonary fibrosis acute exacerbation: defenders or killers?Spyros A Papiris, Effrosyni D Manali, Likourgos Kolilekas, et al.
Pageof 10

Showing results (11-20 of 93) with videos related to

Sort By:
Pageof 10
Lung|November 13, 2013
Treating CTDs related fibrotic ILDs by immunosuppressants: "facts and faults"Spyros A Papiris, Konstantinos Kagouridis, Georgia Papadaki, et al.
Drugs|November 17, 2009
Acute severe asthma: new approaches to assessment and treatmentSpyros A Papiris, Effrosyni D Manali, Likurgos Kolilekas, et al.
Drug Safety|June 18, 2010
Amiodarone: review of pulmonary effects and toxicitySpyros A Papiris, Christina Triantafillidou, Likurgos Kolilekas, et al.
Frontiers in Pharmacology|May 2, 2022
IPF-Acute Exacerbations: Advances and Future PerspectivesSpyros A Papiris, Lykourgos Kolilekas, Konstantinos Kagouridis, et al.
Environmental Health : a Global Access Science Source|August 31, 2021
Long-term personal air pollution exposure and risk for acute exacerbation of idiopathic pulmonary fibrosisIoannis Tomos, Konstantina Dimakopoulou, Effrosyni D Manali, et al.
Expert Review of Respiratory Medicine|March 25, 2014
Idiopathic pulmonary fibrosis acute exacerbations: where are we now?Spyros A Papiris, Konstantinos Kagouridis, Likurgos Kolilekas, et al.
Expert Review of Respiratory Medicine|November 8, 2023
Effects of short-term air pollution exposure on symptoms development in the course of idiopathic pulmonary fibrosisKonstantina Dimakopoulou, Ioannis Tomos, Effrosyni D Manali, et al.
Pneumonologia I Alergologia Polska|September 18, 2015
"Luck's always to blame": silent wounds of a penetrating gunshot trauma sustained 20 years agoIoannis Tomos, Effrosyni D Manali, Stylianos Argentos, et al.
The Lancet. Respiratory Medicine|June 24, 2026
Pulmonary fibrosis in chILD: bridging the gapEffrosyni D Manali, Nadia Nathan, Lykourgos Kolilekas, et al.
American Journal of Respiratory and Critical Care Medicine|March 3, 2012
Steroids in idiopathic pulmonary fibrosis acute exacerbation: defenders or killers?Spyros A Papiris, Effrosyni D Manali, Likourgos Kolilekas, et al.
Pageof 10